FDA Declares End to Semaglutide Shortage; Clock Ticking on Compounded Versions

In the wake of the FDA’s Feb. 21, 2025 announcement declaring an end to the semaglutide shortage, stakeholders in the compounding arena offered their take on the agency’s decision and how it may affect patients’ ability to access—and afford—the blockbuster weight-loss medication.